Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression and delivery of an endolysin to combat Clostridium perfringens

14 Aug 2013

Abstract excerpt

Clostridium perfringens is a cause for increasing concern due to its responsibility for severe infections both in humans and animals, especially poultry. To find new control strategies to treat C. perfringens infection, we investigated the activity and delivery of a bacteriophage endolysin. We identified a new endolysin, designated CP25L, which shows similarity to an N-acetylmuramoyl-L-alanine amidase domain and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacteriophages and microbial interactions
Share to Clostridium difficile and Clostridium perfringens research
Share to Viral gastroenteritis research and epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23942878
DOI: 10.1007/s00253-013-5128-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression and delivery of an endolysin to combat Clostridium perfringensPMID 23942878Read ↗

Bacteriophage endolysins as a potential weapon to combat Clostridioides difficile infectionSemantic proximity Read ↗

A novel chimeric endolysin with enhanced lytic and binding activity against Clostridium perfringensSemantic proximity Read ↗

Exploring the therapeutic potential of endolysin CD27L_EAD against Clostridioides difficile infectionSemantic proximity Read ↗

A Broad-Spectrum Phage Endolysin (LysCP28) Able to Remove Biofilms and Inactivate Clostridium perfringens StrainsSemantic proximity Read ↗

Battling Enteropathogenic Clostridia: Phage Therapy for Clostridioides difficile and Clostridium perfringensSemantic proximity Read ↗

Phages and engineered lysins as an effective tool to combat Gram‐negative foodborne pathogensSemantic proximity Read ↗

Phage-Encoded EndolysinsSemantic proximity Read ↗

Characterization of bacteriophages virulent for Clostridium perfringens and identification of phage lytic enzymes as alternatives to antibiotics for potential control of the bacteriumSemantic proximity Read ↗

Recombinant Limosilactobacillus (Lactobacillus) delivering nanobodies against Clostridium perfringens NetB and alpha toxin confers potential protection from necrotic enteritisSemantic proximity Read ↗

Recombinant Limosilactobacillus (Lactobacillus) delivering nanobodies against Clostridium perfringens NetB and alpha toxin confers potential protection from necrotic enteritisSemantic proximity Read ↗

A Putative Amidase Endolysin Encoded by Clostridium perfringens St13 Exhibits Specific Lytic Activity and Synergizes with the Muramidase Endolysin PsmSemantic proximity Read ↗

Recombinant Expression of Two Bacteriophage Proteins That Lyse Clostridium perfringens and Share Identical Sequences in the C-Terminal Cell Wall Binding Domain of the Molecules but Are Dissimilar in Their N-Terminal Active DomainsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.